Annual CFF
$9.65 M
-$1.01 M-9.50%
31 December 2022
Summary:
Calithera Biosciences annual cash flow from financing activities is currently $9.65 million, with the most recent change of -$1.01 million (-9.50%) on 31 December 2022. During the last 3 years, it has fallen by -$32.41 million (-77.05%). CALA annual CFF is now -92.15% below its all-time high of $122.95 million, reached on 31 December 2017.CALA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$4000.00
-$11.00 K-73.33%
31 December 2022
Summary:
Calithera Biosciences quarterly cash flow from financing activities is currently $4000.00, with the most recent change of -$11.00 thousand (-73.33%) on 31 December 2022. CALA quarterly CFF is now -100.00% below its all-time high of $120.58 million, reached on 31 March 2017.CALA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$9.65 M
-$651.00 K-6.32%
31 December 2022
Summary:
Calithera Biosciences TTM cash flow from financing activities is currently $9.65 million, with the most recent change of -$651.00 thousand (-6.32%) on 31 December 2022. CALA TTM CFF is now -92.49% below its all-time high of $128.60 million, reached on 30 June 2017.CALA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CALA Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -77.0% | +300.0% | -8.2% |
| 5 y5 years | -34.0% | +101.6% | -85.2% |
CALA Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -77.0% | at low | -100.0% | +300.0% | -9.5% | +325.7% |
| 5 y | 5 years | -90.2% | at low | -100.0% | +101.6% | -90.8% | +325.7% |
| alltime | all time | -92.2% | +1042.6% | -100.0% | +101.6% | -92.5% | >+9999.0% |
Calithera Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $9.65 M(-9.5%) | $4000.00(-73.3%) | $9.65 M(-6.3%) |
| Sept 2022 | - | $15.00 K(-99.8%) | $10.31 M(+0.1%) |
| June 2022 | - | $8.50 M(+647.5%) | $10.29 M(+353.8%) |
| Mar 2022 | - | $1.14 M(+73.6%) | $2.27 M(-78.7%) |
| Dec 2021 | $10.67 M(-74.6%) | $655.00 K(>+9900.0%) | $10.67 M(+1.5%) |
| Sept 2021 | - | $1000.00(-99.8%) | $10.51 M(-0.0%) |
| June 2021 | - | $475.00 K(-95.0%) | $10.51 M(-76.1%) |
| Mar 2021 | - | $9.54 M(+1807.4%) | $43.94 M(+4.5%) |
| Dec 2020 | $42.06 M(-57.5%) | $500.00 K(>+9900.0%) | $42.06 M(-49.7%) |
| Sept 2020 | - | $2000.00(-100.0%) | $83.58 M(+0.3%) |
| June 2020 | - | $33.90 M(+342.6%) | $83.33 M(-20.9%) |
| Mar 2020 | - | $7.66 M(-81.8%) | $105.41 M(+6.6%) |
| Dec 2019 | $98.91 M(+576.2%) | $42.02 M(<-9900.0%) | $98.91 M(+51.5%) |
| Sept 2019 | - | -$247.00 K(-100.4%) | $65.30 M(-8.3%) |
| June 2019 | - | $55.98 M(+4751.3%) | $71.24 M(+355.8%) |
| Mar 2019 | - | $1.15 M(-86.3%) | $15.63 M(+6.9%) |
| Dec 2018 | $14.63 M | $8.41 M(+47.7%) | $14.63 M(+83.1%) |
| Sept 2018 | - | $5.69 M(+1405.8%) | $7.99 M(+217.1%) |
| June 2018 | - | $378.00 K(+152.0%) | $2.52 M(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $150.00 K(-91.5%) | $2.52 M(-98.0%) |
| Dec 2017 | $122.95 M(+940.5%) | $1.77 M(+692.8%) | $122.95 M(-2.2%) |
| Sept 2017 | - | $223.00 K(-41.0%) | $125.74 M(-2.2%) |
| June 2017 | - | $378.00 K(-99.7%) | $128.60 M(+0.4%) |
| Mar 2017 | - | $120.58 M(+2543.7%) | $128.15 M(+984.6%) |
| Dec 2016 | $11.82 M(+1298.3%) | $4.56 M(+47.8%) | $11.82 M(+56.4%) |
| Sept 2016 | - | $3.08 M(-4326.0%) | $7.55 M(+59.7%) |
| June 2016 | - | -$73.00 K(-101.7%) | $4.73 M(-6.9%) |
| Mar 2016 | - | $4.24 M(+1314.3%) | $5.08 M(+501.3%) |
| Dec 2015 | $845.00 K(-99.0%) | $300.00 K(+14.5%) | $845.00 K(-98.8%) |
| Sept 2015 | - | $262.00 K(-5.1%) | $72.20 M(-15.1%) |
| June 2015 | - | $276.00 K(+3842.9%) | $85.00 M(-3.2%) |
| Mar 2015 | - | $7000.00(-100.0%) | $87.86 M(-0.0%) |
| Dec 2014 | $87.87 M(+101.4%) | $71.66 M(+448.6%) | $87.87 M(+442.1%) |
| Sept 2014 | - | $13.06 M(+317.6%) | $16.21 M(+415.4%) |
| June 2014 | - | $3.13 M(>+9900.0%) | $3.15 M(>+9900.0%) |
| Mar 2014 | - | $17.00 K | $17.00 K |
| Dec 2013 | $43.63 M(+631.2%) | - | - |
| Dec 2012 | $5.97 M | - | - |
FAQ
- What is Calithera Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for Calithera Biosciences?
- What is Calithera Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Calithera Biosciences?
- What is Calithera Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Calithera Biosciences?
What is Calithera Biosciences annual cash flow from financing activities?
The current annual CFF of CALA is $9.65 M
What is the all time high annual CFF for Calithera Biosciences?
Calithera Biosciences all-time high annual cash flow from financing activities is $122.95 M
What is Calithera Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of CALA is $4000.00
What is the all time high quarterly CFF for Calithera Biosciences?
Calithera Biosciences all-time high quarterly cash flow from financing activities is $120.58 M
What is Calithera Biosciences TTM cash flow from financing activities?
The current TTM CFF of CALA is $9.65 M
What is the all time high TTM CFF for Calithera Biosciences?
Calithera Biosciences all-time high TTM cash flow from financing activities is $128.60 M